TITLE

Autoimmunity and Gene Therapy: The nemesis of autoimmunity

AUTHOR(S)
Giannoukakis, N.; Trucco, M.
PUB. DATE
February 2004
SOURCE
Gene Therapy;Feb2004, Vol. 11 Issue 3, p231
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Outlines the status of gene therapy approaches in autoimmune, type 1 diabetes mellitus. Toxicity associated with adenovirus and herpes vectors; Interaction between the vector recipient and the vector with its encoded transgene product; Reasons why recombinant adeno-associated virus was considered an attractive vectors.
ACCESSION #
12046770

 

Related Articles

  • The application of gene therapy in autoimmune diseases. Seroogy, C M; Fathman, C G // Gene Therapy;Jan2000, Vol. 7 Issue 1, p9 

    The application of gene therapy in autoimmune disease represents a novel use of this technology. The goal of gene therapy in the treatment of autoimmune disease is to restore ‘immune homeostasis’ by countering the pro-inflammatory effects of the CD4+ T cells in the lesions of...

  • Constitutive systemic expression of IL-1Ra or soluble TNF receptor by genetically modified hematopoietic cells suppresses LPS induction of IL-6 and IL-10. Doughty, L A; Patrene, K D; Evans, C H; Boggs, S S; Robbins, P D // Gene Therapy;Mar97, Vol. 4 Issue 3, p252 

    We have been developing both local and systemic gene therapy approaches to treat inflammatory and autoimmune diseases. To determine if systemic, constitutive expression of biologically active anti-inflammatory agents is therapeutic and/or has associated toxicity, mouse hematopoietic stem cells...

  • Immuno- and genetic therapy in autoimmune diseases. Chernajovsky, Y; Dreja, H; Daly, G; Annenkov, A; Gould, D; Adams, G; Croxford, J L; Baker, D; Podhajcer, O L; Mageed, R A // Genes & Immunity;Jun2000, Vol. 1 Issue 5, p295 

    Animal models of autoimmune disease have been developed that mimic some aspects of the pathophysiology of human disease. These models have increased our understanding of possible mechanisms of pathogenesis at the molecular and cellular level and have been important in the testing, development...

  • 365. Aerosol Delivery of an Enhanced Helper-Dependent Adenovirus Formulation to Rabbit Lung Using an Intratracheal Catheter Koehler, David R.; Frndova, Helena; Leung, Kitty; Louca, Emily; Palmer, Donna; Ng, Philip; McKerlie, Colin; Cox, Peter; Coates, Allan L.; Hu, Jim // Molecular Therapy;Jun2005, Vol. 11, p142 

    An abstract of the article "Aerosol Delivery of an Enhanced Helper-Dependent Adenovirus Formulation to Rabbit Lung Using an Intratracheal Catheter," by David R. Koehler, Helena Frndova, Kitty Leung, Emily Louca, Donna Palmer, Philip Ng, Colin McKerlie, Peter Cox, and Allan L. Coates is presented.

  • Tumour angiogenesis as a target for adenoviral mediated antisense gene therapy in human prostate cancer. Wood, C G // Prostate Cancer & Prostatic Diseases;2000 Supplement 1, Vol. 3 Issue 4, pS43 

    Presents information on the development of an adenoviral mediated gene therapy strategy that targets tumor cell production of factors important in the angiogenic cascade. Reduction in tumor cell production; Utilization of reverse transcriptase-polymerase chain reaction.

  • Hide and seek. Le Page, Michael // New Scientist;04/28/2001, Vol. 170 Issue 2288, p11 

    Discusses the use of adenoviruses to sneak past the immune system and deliver missing genes to people with disorders. Process used to deliver genes; Problem with using adenoviruses for gene therapy; Result of using gene therapy to treat people with cystic fibrosis.

  • Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: long- term remission of liver metastases in a mouse model. Martinet, Olivier; Ermekova, Vanadyia; Martinet, O; Ermekova, V; Qiao, J Q; Sauter, B; Mandeli, J; Chen, L; Chen, S H // JNCI: Journal of the National Cancer Institute;06/07/2000, Vol. 92 Issue 11, p931 

    Background: The success of immunomodulatory cancer therapy is frequently hampered by the transient nature of the antitumor immune response. We have shown previously in a mouse model that interleukin 12 (IL-12) generates a strong natural killer (NK) cell-mediated antitumor response...

  • Gene Therapy Using IL-12 Family Members in Infection, Auto-Immunity, and Cancer. Waldner, Maximilian J.; Neurath, Markus F. // Current Gene Therapy;Aug2009, Vol. 9 Issue 4, p239 

    Interleukin-12 (IL-12) is known for several years to have an essential role in inflammatory responses and innate resistance to infection and cancer. This has been largely attributed to its ability to initiate the differentiation of T-helper-1 (Th1) cells producing interferon-gamma. Recently, two...

  • Adenoviral Vectors for Cancer Gene Therapy. Wenli Zhao, S.; Kobayashi, Masanobu; Hosokawa, Masuo; Seth, Prem // Current Genomics;Jun2002, Vol. 3 Issue 3, p163 

    Cancer gene therapy is considered a very viable approach for the treatment of cancer. The basic idea is to introduce the therapeutic gene, often in the form of a foreign cDNA, into the cancer or other appropriate target cells. For gene delivery purposes, several viral and non-viral vectors have...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics